Christopher Ryan

Trials

Studies that name Christopher Ryan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:11 UTC. Open this list on ClinicalTrials.gov

• Early Ph1
  NCT03960177 · Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma

  OHSU Knight Cancer Institute · completed · Osteosarcoma · principal investigator
• Ph2
  NCT02050919 · Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

  OHSU Knight Cancer Institute · completed · Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 · principal investigator
• Ph1/Ph2
  NCT00684996 · Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer

  National Cancer Institute (NCI) · terminated · Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer · principal investigator
• Ph2
  NCT00101114 · Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

  National Cancer Institute (NCI) · completed · Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer · principal investigator
• Ph2
  NCT00042952 · Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

  National Cancer Institute (NCI) · terminated · Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Southwest Oncology Group Treatment Grant
  U10CA032102 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES D. BLANKE · fiscal years 1985 to 2013
  Named on NCT00684996, NCT00101114
• Cancer and Leukemia Group B
  U10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 1985 to 2013
  Named on NCT00042952